Santen Pharmaceutical Co. Ltd. Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Santen Pharmaceutical Co. Ltd.

Santen Pharmaceutical Co. Ltd.

Santen Pharmaceutical Co. Ltd. ADR
Stock Exchange	Other OTC
EPS	$0.71
Market Cap	$6.62 B
Shares Outstanding	399.83 M
Public Float	-

Santen Pharmaceutical Co. Ltd.
Stock Exchange	Frankfurt Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	407.02 M
Public Float	-

Santen Pharmaceutical Co. Ltd.
Stock Exchange	Tokyo Stock Exchange
EPS	JPY78.43
Market Cap	JPY718.09 B
Shares Outstanding	399.83 M
Public Float	337.52 M

Profile

Address	Grand Front Osaka Tower A, 25/F Osaka Osaka 530 Japan
Employees	-
Website	http://www.santen.co.jp
Updated	07/08/2019
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the Pharmaceuticals and Other segments. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products.

Financials

Akira Kurokawa

Chairman & Chief Executive Officer

Shigeo Taniuchi

President, COO & Representative Director